StockData
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31

SKINVISIBLE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026

Market cap
$843.54K
P/E (TTM)
–
Dividend yield
–

SKINVISIBLE, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Skinvisible does not break out revenue by segment, region or product in the tagged data of its filings for this period type.